Page 23 - Early Access Program News Today

Consumer Reports, in its latest test of Active Driver Assist software by 12 manufacturers ranked Tesla number 7 writing “Tesla autopilot falls to midpack as other high-tech systems improve.” Consumer Reports adds saying "that’s because Tesla hasn’t changed Autopilot’s basic functionality much since it first came out."

/PRNewswire/ -- Semarchy, a master data management and data integration leader, announces the launch of data-driven workflows for their award-winning xDM...

Research collaboration will evaluate the potential of AIM's Ampligen® (rintatolimod) in combination with AstraZeneca's Imfinzi (durvalumab) for the treatment of pancreatic cancerOCALA, Fla., Jan. 17, 2023

FSD Beta v11 is expected to bring vector spaces and use of all 8 cameras to highway driving. And even though since early November Tesla has released FSD beta v11 to internal employees, we have yet to see the software in action in the real world. However, now Elon Musk says the software "should start rolling out later this week, next week at the latest."

Partnership offers treatment access to hundreds of patients across several European countries - News - PharmaTimes

/PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered in Italy, today announced that it has partnered with Avanzanite Bioscience...

SIFI Announces License Agreement With Avanzanite Bioscience for Akantior® - read this article along with other careers information, tips and advice on BioSpace

- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive ("NRG1+") cancer have been treated with zenocutuzumab ("Zeno") monotherapy - Petosemtamab clinical update planned for first

- As of year-end 2022, more than 150 patients with NRG1 gene fusion positive (“NRG1+”) cancer have been treated with zenocutuzumab (“Zeno”) monotherapy -...

Live video webcast on Wednesday, January 18th at 11:00 AM ET...